KT

Kali Therapeutics at Festival of Biologics 2026

Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website

Kali Therapeutics takes part in 2 sessions at Festival of Biologics 2026 in Basel. Its program pairs fast manufacturing development with new antibodies for autoimmune disease. Topics include a playbook that took a T cell engager from sequence to clinic in 14 months and a trispecific antibody, one that binds three targets, for treating autoimmune diseases.

OrganizationFestival of Biologics 2026 Attendance
KT
Kali Therapeutics
Talk
Wed Oct 14
15:30
From Sequence to Clinic in 14 Months: An Accelerated CMC Playbook for TCEs
How to speed up manufacturing and quality testing so T cell engagers, antibodies that recruit T cells, reach first human trials sooner.
Talk
Thu Oct 15
11:40
A novel trispecific antibody for treating autoimmune diseases
Disease Areas: Inflammation & Autoimmune

Explore the full Festival of Biologics 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Festival of Biologics 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Kali Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction